Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2025
Preclinical and pilot clinical evaluation of novel dual-modality pet/fluorescence probes targeting FAP for accurate tumor margin delineationLiang Zhao, Yizhen Pang, Daqiang Xu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2020
Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findingsHaojun Chen, Liang Zhao, Dan Ruan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 31, 2020
Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancerHaojun Chen, Yizhen Pang, Jingxun Wu, et al.
The Journal of Clinical Investigation|November 7, 2024
68Ga-MY6349 PET/CT imaging to assess Trop2 expression in multiple types of cancerHaojun Chen, Liang Zhao, Yizhen Pang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2025
177Lu-LNC1004 Radioligand Therapy in Patients with End-stage Metastatic Cancers: A Single-Center, Single-Arm, Phase II StudyHao Fu, Jingxiong Huang, Liang Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2023
Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation StudyHao Fu, Jingxiong Huang, Tianzhi Zhao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 1, 2025
Fibroblast activation protein-targeted PET/CT with 68Ga-FAPI-46 for evaluation of structural damage and inflammation in axial spondyloarthritis: a prospective studyYangchun Chen, Lingyu Yu, Shiju Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2025
68Ga-NK224 PET/CT for Non-Invasive Evaluation of PD-L1 Expression and Inter-Tumor Heterogeneity: A Translational Exploratory StudyLiang Zhao, Yizhen Pang, Yi Ding, et al.
Signal Transduction and Targeted Therapy|June 2, 2024
Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockadeLiang Zhao, Yizhen Pang, Yangfan Zhou, et al.
Pageof 8